NovaBridge Biosciences Deferred Tax Liabilities, Intangible Assets
NovaBridge Biosciences (NBP) had Deferred Tax Liabilities, Intangible Assets of CNY 17.72 million as of 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2024-04-30
- 2023-12-31: Deferred Tax Liabilities, Intangible Assets 17.72M CNY.
- 2022-12-31: Deferred Tax Liabilities, Intangible Assets 17.83M CNY.
- 2021-12-31: Deferred Tax Liabilities, Intangible Assets 17.95M CNY.
- 2020-12-31: Deferred Tax Liabilities, Intangible Assets 18.07M CNY.
CNY
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2023-12-31 | 17.72M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 17.83M CNY 20-F · filed 2024-04-30 |
| 2021-12-31 | 17.95M CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 18.07M CNY 20-F · filed 2022-04-29 |
| 2019-12-31 | 37.21M CNY 20-F · filed 2021-04-28 |
| 2018-12-31 | 37.21M CNY 20-F · filed 2021-04-28 |
| 2017-12-31 | 37.21M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2023-12-31 | $2.50M 20-F · filed 2024-04-30 |
| 2022-12-31 | $2.58M 20-F · filed 2023-05-01 |
| 2021-12-31 | $2.82M 20-F · filed 2022-04-29 |
| 2020-12-31 | $2.77M 20-F · filed 2021-04-28 |
| 2019-12-31 | $5.34M 20-F · filed 2020-04-29 |